• About Us
    • Contact Us
    • Login
    • ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
About Us Contact Us Login ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
Grand Rounds

Meta-Analysis: Are Balloon Catheters or Vaginal Prostaglandins Better for Labor Induction?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Jones et al. (The Lancet, 2022) compared the effectiveness and safety profiles of balloon catheters vs vaginal prostaglandins for cervical ripening

METHODS:

  • Individual participant data meta-analysis
  • Study inclusion criteria
    • RCTs
    • Studies that compared balloon catheter with vaginal prostaglandins for cervical ripening
  • Study design
    • Investigators associated with eligible trials approached to share participant-level data
      • Data subsequently harmonized and recoded based upon predefined definitions of variables
      • Main analysis was by intention to treat
      • Primary meta-analysis used random-effects models
    • All models were adjusted for maternal age and parity
  • Primary outcomes
    • Cesarean delivery
    • Indication for cesarean delivery
    • A composite adverse perinatal outcome
    • A composite adverse maternal outcome

RESULTS:

  • 12 studies (original data available) | 43 studies did not share data
    • 5460 participants
  • Prostaglandin groups
    • PGE2 (dinoprostone): 8 trials
    • PGE1 (misoprostol): 3 trials
    • Both PGE1 and PGE2: 1 trial
  • Balloon groups
    • Single balloon: 8 trials
    • Double balloon: 3 trials
    • Both options: 1 trial
  • There was no significant difference in the rate of cesarean delivery
    • Cesarean delivery
      • Crude incidence 27.0%
      • Adjusted odds ratio (aOR) 1.09 (95% CI, 0.95 to 1.24)
      • 12 trials | 5414 women
    • Cesarean delivery for failure to progress
      • aOR 1.20 (95% CI, 0.91 to 1.58)
      • 11 trials | 4601 women
    • Cesarean delivery for fetal distress
      • aOR 0.86 (95% CI, 0.71 to 1.04)
      • 10 trials | 4441 women
  • The composite adverse perinatal outcome was lower in women who were allocated to balloon catheters
    • Crude incidence 13.6%
    • aOR 0.80 (95% CI, 0.70 to 0.92)
    • 10 trials | 4452 neonates
  • There was no significant difference in the composite adverse maternal outcome
    • Crude incidence 22.7%
    • aOR 1.02 (95% CI, 0.89 to 1.18)
    • 10 trials | 4326 women

CONCLUSION:

  • For labor induction, balloon catheters were associated with similar cesarean rates compared to vaginal prostaglandins but improved composite perinatal outcomes 
  • The authors state

Balloon catheters have been repeatedly proven to be effective in labour induction, are inexpensive, and do not require any specialised preparation or conditions for storage

Learning to insert balloon catheters is possible for a range of clinician skill levels

Balloon catheters have long been used for cervical ripening, and the significant reduction in adverse perinatal outcomes provides the rationale to recommend balloon catheters as the preferred choice 

  • In an accompanying expert commentary, the authors
    • Note that different catheters as well as different prostaglandins were combined
    • Cite a recent Cochrane review (see ‘Related ObG Topics’ below) regarding misoprostol’s low rates of fetal and maternal adverse effects and state that low-dose oral misoprostol is ‘probably the optimal method’ for induction

Learn More – Primary Sources:

Balloon catheters versus vaginal prostaglandins for labour induction (CPI Collaborative): an individual participant data meta-analysis of randomised controlled trials

Comment: Induction of labour: first, do no harm

Want to stay on top of key guidelines and research papers?

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Is There a Link between Induction of Labor and Cesarean Delivery?
Meta-Analysis: Does Outpatient Cervical Ripening with Balloon Catheter Decrease Time Spent on Labor and Delivery?
2021 Cochrane Review: Oral Misoprostol vs Other Labor Induction Methods

Sections

  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • COVID-19

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site